Follow
Rachael M Zemek
Rachael M Zemek
Verified email at telethonkids.org.au
Title
Cited by
Cited by
Year
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ...
Science translational medicine 11 (501), eaav7816, 2019
1802019
Sensitizing the tumor microenvironment to immune checkpoint therapy
RM Zemek, WL Chin, AK Nowak, MJ Millward, RA Lake, WJ Lesterhuis
Frontiers in immunology 11, 223, 2020
602020
Tumor infiltrating effector memory antigen-specific CD8+ T cells predict response to immune checkpoint therapy
N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ...
Frontiers in Immunology 11, 584423, 2020
512020
Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103 and XCR1+CD103+ dendritic cells
B Wylie, E Seppanen, K Xiao, R Zemek, D Zanker, S Prato, B Foley, ...
Oncoimmunology 4 (8), e1019198, 2015
352015
Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
RM Zemek, VS Fear, C Forbes, E de Jong, TH Casey, L Boon, ...
Nature Protocols 15 (5), 1628-1648, 2020
222020
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
RM Zemek, WL Chin, VS Fear, B Wylie, TH Casey, C Forbes, CM Tilsed, ...
Nature Communications 13 (1), 1-16, 2022
142022
Retinoic acid induces an IFN-driven inflammatory tumour microenvironment, sensitizing to immune checkpoint therapy
CM Tilsed, TH Casey, E de Jong, A Bosco, RM Zemek, J Salmons, G Wan, ...
Frontiers in Oncology 12, 849793, 2022
72022
CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy
CM Tilsed, N Principe, J Kidman, WL Chin, MLO Morales, RM Zemek, ...
Cell Reports 41 (13), 2022
62022
PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
MLO Morales, CA Rinaldi, E de Jong, SM Lansley, JPA Gummer, B Olasz, ...
Iscience 25 (1), 2022
62022
A mouse model of incompletely resected soft tissue sarcoma for testing (Neo) adjuvant therapies
FX Rwandamuriye, BJ Weston, TG Johns, WJ Lesterhuis, RM Zemek
MyJoVE Corporation, 2020
52020
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment. Sci. Transl. Med. 11, eaav7816
RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ...
52019
Functional genomics in cancer immunotherapy: computational approaches for biomarker and drug discovery
WL Chin, RM Zemek, WJ Lesterhuis, T Lassmann
Molecular Systems Design & Engineering 4 (4), 689-700, 2019
42019
A surgically optimized intraoperative poly (I: C)-releasing hydrogel prevents cancer recurrence
FX Rwandamuriye, CW Evans, B Wylie, M Norret, B Vitali, D Ho, ...
Cell Reports Medicine 4 (7), 2023
22023
Celebrating 100 years of Immunology & Cell Biology – a special focus on the field of tumor immunology in Australia
S Kumari, RM Zemek, U Palendira, LM Ebert
Immunology and Cell Biology 101 (9), 783-788, 2023
12023
Method for immunotherapy drug treatment
WJ Lesterhuis, R Lake, R Zemek, A Bosco, E De Jong
US Patent App. 16/979,962, 2021
12021
Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner
CM Tilsed, MLO Morales, RM Zemek, BA Gordon, MJ Piggott, AK Nowak, ...
BMC cancer 24 (1), 203, 2024
2024
1226 Surgery is a window of opportunity: biomaterial-assisted delivery of immunotherapy reduces local recurrence of soft tissue sarcoma
BC Wylie, F Rwandamuriye, C Evans, M Norrett, RM Zemek, S Iyer, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
ML Orozco Morales, CA Rinaldi, E de Jong, SM Lansley, YCG Lee, ...
Plos one 18 (5), e0274364, 2023
2023
Early Clonal Expansion of Tumour-Infiltrating Lymphocytes Predicts Response to Immune Checkpoint Therapy
J Kidman, R Zemek, JW Sidhom, D Correa, N Principe, F Sheikh, VS Fear, ...
2022
Tumor Antigen-Specific Infiltrating CD8+ Effector T Cells Memory Predict Response to Immune Checkpoint Therapy
N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ...
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20